# Nichols

> District Court, S.D. Illinois · December 3, 2025

URL: https://www.frixlaw.com/law-library/cases/11213744

## Case

- **Full name:** Demetrius H. Nichols, deceased by and through Diane Jones his sister and next best friend and Administrator of the Estate of Demetrius H. Nichols v. Wexford Health Sources, Inc., Dr. Mohammed Z. Siddiqui, N.P. Ali Dearmond, and Dr. Stephen Ritz
- **Court:** District Court, S.D. Illinois
- **Decided:** December 3, 2025
- **Opinion:** 100trialcourt
- **Cited by:** 0 later opinions in the Frix Law Library

## Citator (automated)

- No negative treatment found by the automated citator. That is not the same as a confirmation that the case is good law; read the citing cases.
- Full citator and citing cases: https://www.frixlaw.com/law-library/cases/11213744

## How later opinions describe it (automated extraction)

- observing that asthma, “depending upon its degree, can be a serious medical condition”

## Opinion text

IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF ILLINOIS

DEMETRIUS H. NICHOLS, deceased by )
and through DIANE JONES his sister and )
next best friend and Administrator of the )
Estate of DEMETRIUS H. NICHOLS, )
) Case No. 24-cv-796-SMY
Plaintiff, )
)
vs. )
)
WEXFORD HEALTH SOURCES, INC., )
DR. MOHAMMED Z. SIDDIQUI, )
N.P. ALI DEARMOND, and )
DR. STEPHEN RITZ, )
)
Defendants. )

MEMORANDUM AND ORDER

YANDLE, District Judge:
On January 28, 2021, Demetrius Nichols died while incarcerated at Menard Correctional
Center. Plaintiff Diane Jones, Administrator of the Estate of Demetrius Nichols, filed this action
against Wexford Health Sources, Inc. (“Wexford”), Dr. Mohammed Siddique, Ali Dearmond, NP,
Dr. Stephen Ritz, Dr. Hector Garcia, Dr. Kurt Osmundson, and Tammie Rable, asserting violations
of 42 U.S.C § 1983 and state law claims for wrongful death and survival. Plaintiff’s claims against
Defendants Garcia, Osmundson, and Rable have been resolved (see Docs. 111, 121).
Plaintiff states the following causes of action in the First Amended Complaint:

Count I: Eighth Amendment deliberate indifference claim under 42 U.S.C. §
1983 against Defendants Siddique, Ritz, and Dearmond in their
individual capacities and as Wexford employees/agents;

Count II: Wrongful death under the Illinois Wrongful Death Act against
Wexford;

Count III: An Illinois Survival Action claim against Wexford; and
Count IV: A Monell claim under 42 U.S.C. § 1983 against Wexford.1

This matter is now before the Court for consideration of the motion for summary judgment
filed by the remaining Defendants (Doc. 125) and the partial motion for summary judgment filed
by Plaintiff (Doc. 130). The motions are fully briefed. For the following reasons, Defendants’
Motion is GRANTED in part and DENIED in part; Plaintiff’s Motion is DENIED.
Factual Background
Construed in the light most favorable to the nonmoving party, the evidence and reasonable
inferences establish the following facts relevant to the pending summary judgment motions:
Nasal Polyps and Prednisone
Nasal polyps are caused by severe inflammation of the lining of the nose and sinuses that
result in mucus -filled polyps throughout the nasal system (Doc. 139-2, pp. 85-86; Doc. 139-3, pp.
22-23). Nasal polyps interfere with the ability to draw air through the nasal passages and with the
normal drainage and ventilation of the sinuses, causing nasal pressure and pain (Doc. 139-3, pp.
24-27; Doc. 139-4, p. 70). The mucus produced by nasal polyps puts pressure on the sinuses and

causes postnasal drip down the back of the throat (Doc. 139-3, pp. 26-27). Individuals with nasal
polyps tend to be more susceptible to bacterial infections (Doc. 139-4, p. 84).
An obstruction in the sinuses from nasal polyps when you suffer from asthma can be very
serious (Doc. 141-2, p. 70). Asthma can also cause a thick mucus in addition to constricting
airways. Id. at p. 91. The removal of obstructive nasal polyps is an important part of managing
asthma as patients who have their nasal polyps removed tend to have fewer asthma attacks (Doc.
139-2, pp. 85-86).

1 Plaintiff concedes that the alleged deliberate indifference by the individual defendants cannot support an Eighth
Amendment claim traceable to Wexford and voluntarily dismisses her Monell claim. See Doc. 150, at p. 23.
Accordingly, Count IV is DISMISSED with prejudice.
Corticosteroids like Prednisone have short-term and long-term side effects, including
immunosuppression, increased risk for other diseases, recurrent infection, suppression of the
adrenal glands, and immune separation (Doc. 126-14, p. 145; Doc. 126-8, p. 69; Doc. 126-10, p.
37; Doc. 126-15, pp. 53-54). Oral steroids may help by temporarily shrinking nasal polyps.
However, they are not appropriate for recurring daily use and should be used sparingly. (Doc.

126-8, pp. 62-63, 68-69). According to Wexford’s Medical Director at Menard, Dr. Siddiqui, there
are dangers to taking Prednisone daily for extended periods of time and it “should be taken as few
times, and as little as possible” (Doc. 126-14, pp. 154-155).
Nichols’ Medical History
In 2013, Wexford approved a referral for an Ear, Nose, and Throat (“ENT”) specialist to
evaluate and treat Nichols’ obstructive nasal polyps while he was an inmate at Dixon Correctional
Center. Nichols subsequently underwent a polypectomy, a surgical procedure to remove the nasal
polyps and reconstruct his sinus cavity (Doc. 139-5, p. 4).
Nichols subsequently transferred to Illinois River Correctional Center (“Illinois River”).

In a seven-month period at Illinois River, Nichols was prescribed tapered doses of Prednisone on
six occasions to address his asthma and obstructive nasal polyps: June 16, 2019 through August 9,
2019, 5 mg every day; September 3, 2019, 40 mg. for 7 days; October 8, 2019, 40 mg. for 7 days;
November 19, 2019, 10 mg daily for 3 days increased to 40 mg for 7 days, reduced to 20 mg. for
3 days; January 7, 2020, 40mg for 7 days, reduced to 20 mg. for 3 days and 10 mg for 3 days; and
February 11, 2020, 40 mg for 7 days, reduced to 20 mg. for 7 days (Doc. 140-7, pp. 668, 672, 680,
682, 694, 688, 698, 700).
On February 11, 2020, Dr. Kurt Osmundson observed swelling nasal polyps in both of
Nichols’ nostrils despite repeated doses of Prednisone; he requested an outside ENT evaluation
(Doc. 149-1, p. 493, 587; Doc. 149-2, pp. 8-12). That same day, Dr. Osmundson submitted a
request to Wexford for a referral for Nichols to be examined by an ENT specialist for “obstructed
nasal polyps” per Wexford’s “collegial review” protocol (Doc. 139-2, p. 291; Doc. 140-6, p. 587).
On February 18, 2020, Wexford Utilization Management (UM) Director Dr. Garcia approved the
request for the ENT referral (Doc. 141-1, pp. 32-33; Doc. 140-6, p. 585). The Wexford approval

for the ENT referral specifically stated that Nichols had a polypectomy in 2013 and was “treated
multiple times with Prednisone and antibiotics without relief” (Doc. 139-2, pp. 291-292; Doc. 139-
3, p. 38; Doc. 140-6, p. 585). Dr. Stephen Ritz testified the reason the Wexford approval stated
Nichols was “treated multiple times with Prednisone and antibiotics without relief” was to explain
why the service was medically necessary from a clinical standpoint. There would be no need for
an outside referral if Prednisone was effective (Doc. 141-1, pp. 52-53).
On February 27, 2020, Nichols was transferred from Illinois River to Menard Correctional
Center (Doc. 140-5, pp. 496-497; Doc. 141-1, p. 33). Wexford providers at Menard prescribed
Prednisone to Nichols ten more times from March 2020 until his death in January 2021, despite

the documentation in his medical records that Prednisone provided no relief (Doc. 126-5, pp. 765-
775).
The protocol at Menard for an inmate to see a doctor or nurse practitioner (“NP”) is for the
inmate to submit a written request or kite that is screened by a registered nurse (“RN”) who then
schedules the inmate for an assessment. Following the assessment, the nurse decides if the inmate
should be scheduled for an evaluation by a doctor or NP (Doc. 141-3, pp. 25, 30-31).
Due to the COVID-19 global pandemic and Governor Pritzker’s March 13, 2020 Order, on
March 20, 2020, the Illinois Department of Corrections (“IDOC”) was placed on an Administrative
Quarantine and all non-emergent medical furloughs (offsite appointments) were prohibited until
June 15, 2020 (Doc. 126-6, p. 88-89; 102-107; 312-313; 632; Doc. 126-14, pp. 158-160).
Nichols filed a grievance on March 18, 2020 about the ENT referral, stating he was in
“constant pain from nasal polyps,” and having difficulty breathing (Doc. 139-2, pp. 286-287; Doc.
139-3, pp. 50-51; Doc. 141-5). On March 20, 2020, Nichols was seen by RN Burns for his nasal

polyps. (Doc. 141-2, pp. 42-43). Burns noted Nichols’ nasal cavity was not visible due to drainage
and referred him the to the medical provider call line (“MDCL”). Id.
On March 23, 2020, Southern Illinois Hospital (“SIH”) ENT received Nichols’ referral and
PA Jill Absher triaged his case as “first avail ok,” meaning his appointment was non-emergent and
he would be scheduled for the next available new patient appointment (Doc. 126-7, p. 685; Doc.
126-8, pp. 35-36). SIH attempted to call Menard multiple times to schedule the appointment in
March and April 2020, with no response. The referral expired (Doc. 126-8, pp. 33-35).
On March 24, 2020, Nichols was seen by NP Michael Moldenhauer who noted the large
nasal polyps affected Nichols’ “nasal resonance voice-deficit” (Doc. 141-2, pp. 43-44; Doc. 140-

6, p. 503). Moldenhauer consulted with Dr. Siddiqui and prescribed Nichols a tapered dose of
Prednisone for 4 weeks (40 mg daily for 7 days, 20 mg daily for 7 days, 10 mg daily for 2 weeks,
and then stop) (Doc. 141-2, pp. 43-44, 148-149; Doc. 139-3, p. 45; Doc. 140-6, pp. 506-508; Doc.
141-6, p. 765). On March 25, 2020, Wexford again authorized the outpatient ENT evaluation for
Nichols which stated that Nichols had a previous polypectomy in 2013 and been “treated multiple
times with Prednisone without relief.” (Doc. 141-2, pp. 48-49; Doc. 140-6, p. 586).
Nichols was admitted to the infirmary on April 24, 2020 for a 23-hour observation because
of shortness of breath, coughing, and wheezing. (Doc. 141-2, pp. 53-54; Doc. 140-6, pp. 506-507).
Based on his age and weight, Nichols had an expected peak flow of 575. (Doc. 139-2, pp. 223-
224). On April 24, 2020, his peak flow measurements were 250-200-250 (Doc. 126-5, pp. 506-
507). Moldenhauer prescribed Nichols another 4-week tapered dose of Prednisone (40mg daily
for 7 days, 20 mg daily for 7 days, 10 mg daily for 2 weeks, and then stop). (Doc. 141-2, p. 149;
Doc. 141-6, p. 766).
Due to the Covid-19 pandemic, Menard was on a state mandated lockdown and was unable

to schedule outside medical furloughs from May to June 2020. (Doc. 139-3, pp. 64-65). On June
9, 2020, NP Mary Jo Zimmer admitted Nichols to the Menard Health Care Unit (“HCU”) with
complaints of shortness of breath and severe nasal polyps. (Doc. 141-2, pp. 62-63; Doc. 140-6, pp.
514-519). Nichols’ peak flow measurements were 175-150-200 (Doc. 126-5, pp. 516-517).
Moldenhauer prescribed Nichols another tapered 2-week dose of Prednisone (40mg daily for 3
days, 30 mg daily for 3 days, 20 mg daily for a week). (Doc. 141-2, pp. 149-150; Doc. 141-6, p.
768). Zimmer spoke to medical furlough clerk Elizabeth Young and told her Nichols’ outside
ENT evaluation “need[ed] to be a priority” (Doc. 139-3, p. 65; Doc. 139-2, p. 289; Doc. 140-6, p.
514). Offsite scheduling at Menard was handled by the site schedulers (Doc. 126-14, pp. 19-20,

35, 86-87; Doc. 126-15, pp. 14, 58; Doc. 126-13, pp. 19-20).
On July 27, 2020, Nichols sent a sick call note that he needed to be seen by a doctor as
soon as possible for his nasal polyps (Doc. 140-8, p. 808). On July 29, 2020, he was seen by RN
Lakita Burns and assessed for constant pain caused by the nasal polyps in both nostrils, reporting
his pain level was 10 out of 10 (Doc. 141-2, p. 87; Doc. 140-6, p. 525). Moldenhauer prescribed
Nichols another 20-day tapered dose of Prednisone for the nasal polyps on July 30, 2020 (20mg
daily for 10 days, 10 mg daily for 10 days, and then stop) (Doc. 141-2, pp. 88-89, p. 150; Doc.
141-6, p. 769).
Nichols filled out another sick call request on August 17, 2020 stating that his nasal polyps
were swollen and causing difficulty in breathing (Doc. 141-3, pp. 46-47). On August 18, 2020,
RN Melissa Ogle noted that Nichols continued to suffer from pain due to nasal polyps and that she
was unable to examine inside of his nose at cell front because of the size of the polyp. Nichols
rated the aching pain from the polyps as 10 out of 10 for a duration of weeks (Doc. 141-2, p. 89;

Doc, 141-3, pp. 48-49; Doc. 140-6, pp. 530-531).
On August 22, 2020, Nichols filled out another sick call request saying that the nasal polyps
were swelling again and making it difficult for him to breathe (Doc. 141-3, pp. 53-54). On August
24, 2020, RN Shelby Dunn’s progress note stated the nasal polyps were visible and Nichols
complained of constant and stabbing pain, rating it a 10 out of 10 (Doc. 141-3, pp. 50-51; Doc.
141-2, p. 90; Doc. 140-6, p. 531). Dunn noted his eyes were visibly watering due to the pain. Id.
On August 31, 2020, NP Ali Dearmond prescribed Nichols another 20-day tapered dose of
Prednisone (20mg daily for 10 days, 10 mg daily for 10 days, and then stop). (Doc. 141-2, p. 150;
Doc, 141-3, p. 56; Doc. 141-6, p. 769).

On September 2, 2020, Dearmond noted that Nichols complained he could not breathe
because of the large polyps in his nose (Doc. 141-3, pp. 58-60; Doc. 141-2, pp. 92-95; Doc. 140-
6, p. 533). Dearmond prescribed Nichols a 125 IM shot of Solumedrol, 1 spray in each nostril
daily of Nasacort spray, and continued him on the Prednisone that was previously prescribed on
August 31, 2020, allowing him to keep it on his person (“KOP”). Id.; Doc. 141-6, p. 769.
Solumedrol is a corticosteroid that acts as a more potent, immediate, and short-term suppression
than oral Prednisone (Doc. 139-3, p. 48). On September 5, 2020, Nichols complained to RN Lee
Gregson of sinus polyps, drainage, and a cough (Doc. 140-6, p. 534).
The ENT referral approved by Wexford on February 20, 2020, did not take place until
September 16, 2020 (Doc. 141-2, pp. 75-77; Doc. 139-4, p. 12). On September 16, 2020, Nichols
was evaluated by Absher of SIH to address the obstructive nasal polyps. (Doc. 139-4, pp. 6, 11-
12). Absher documented the nasal polyps were a “total obstruction” within Nichols’ sinus cavity.
(Doc. 139-4, pp. 16-17, 69). Absher ordered a CT scan for the sinuses and follow up with ENT

Dr. Mann to plan for another polypectomy to surgically remove the obstructive nasal polyps. (Doc.
139-4, pp. 17-21; Doc. 141-7, p. 662). Absher did not order the CT scan to be completed urgently
because she did not observe an acute problem or infection. (Doc. 139-4, pp. 53-54, 60). She did
not have concerns that Nichols was immunosuppressed or immune compromised when she
assessed Nichols on September 16, 2020, as he did not exhibit any symptoms of lung, urinary, or
other infections. Id. at p. 60. Absher recommended that Nichols increase his use of Nasacort,
previously prescribed on September 2, 2020, to two sprays twice a day to prep for the CT scan.
She also recommended a Prednisone taper to potentially temporarily reduce swelling for the CT
scan. (Doc. 139-4, pp. 18-19, p. 62; Doc. 141-7, p. 591).

On September 21, 2020, Moldenhauer prescribed a 30-day prescription of Prednisone for
Nichols (10 mg daily for one month). (Doc. 141-2, p. 152; Doc. 141-6, p. 771). Dr. Siddiqui
modified Nichols’ Prednisone prescription on September 24, 2020 to a tapered dosage over the
next month. (7.5 mg daily for one week, 5mg daily for 2 weeks, 2.5 mg daily for one week) (Doc.
141-2, pp. 151-152). Dr. Siddiqui had access to the previous prescription orders for Nichols and
knew that Nichols had been prescribed Prednisone for extended daily use since March. (Doc. 141-
2, pp. 154-155). Dr. Ritz and Dr. Siddiqui had another “collegial review” and approved the sinus
CT scan requested by Absher on September 24, 2020 (Doc. 141-1, p. 41). The Wexford “Notice
of Approval” for the CT scan specifically stated that Nichols was “treated multiple times with
Prednisone and antibiotics without relief.” (Doc. 140-7, p. 601; Doc. 141-1, pp. 41-42).
On October 15, 2020, Nichols reported that the steroids (Prednisone) “work[ed] good” and
his condition had improved. (Doc. 126-5, p. 546). However, on November 6, 2020, he reported to
RN Sharon Rogers that the nasal polyps were swollen and causing breathing trouble and requested

to see a medical provider. (Doc. 141-3, p. 80; Doc. 140-6, p. 548). On November 10, 2020,
Moldenhauer prescribed him 5 mg of Prednisone daily for two weeks. (Doc. 141-2, p. 152; Doc.
141-6, p. 772). On November 13, 2020, Nichols was admitted to the infirmary on 23-hour watch
for shortness of breath for the third time complaining that the “nasal polyps made his breathing
worse” and received a shot of 125 IM Solumedrol, a corticosteroid injection and nebulizer
treatment. (Doc. 141-3, pp. 82-84; Doc. 139-3, p. 50; Doc. 140-6, pp. 549-553; Doc. 141-6, p.
772).
Nichols received a CT scan at SIH Herrin Hospital on December 1, 2020. Dr. Michael E.
Thomas stated the findings were “near complete opacification of right maxillary sinus,” meaning

that the obstruction was severe and the sinus cavities were completely blocked. (Doc. 139-4, pp.
23-25). Dr. Siddiqui reviewed the CT scan report and incorrectly documented that the results were
negative and nasal polyps were not seen. He did not request an ENT follow up appointment as
requested by Absher. (Doc. 141-2, pp. 109-110; Doc. 139-4, pp. 29-30; Doc. 140-6, p. 558). On
December 4, 2020, RN Ogle reported that Nichols’ swollen nasal polyps were causing him
difficulty in breathing, rating the pain an 8 out of 10. (Doc. 141-2, pp. 114-115; Doc. 141-3, pp.
91-92; Doc. 140-6, p. 560).
On December 6, 2020, Nichols was admitted to the HCU for shortness of breath by RN
Engelhardt, who noted a large nasal polyp visibly protruding from his left nostril and requested he
be seen by a provider. (Doc. 140-6, pp. 564-565). On December 7, 2020, Dr. Siddiqui did not see
Nichols but conducted a “jacket review” of his medical file and requested a follow up appointment
with the ENT “ASAP.” (Doc. 141-2, pp. 117-120; Doc. 140-6, p. 562). According to Dr. Siddiqui,
he wanted the appointment “expedited” because of the obstructive nasal polyp was “visibly
hanging from the nose.” (Doc. 141-2, pp. 121-122). The expedited follow up appointment never

occurred (Doc. 141-2, pp. 164-166; Doc. 139-5, pp. 9, 24-25). As the physician that ordered the
follow-up referral, it was Dr. Siddiqui’s responsibility to monitor the referral and ensure it took
place. (Doc. 141-3, p. 23; Doc. 141-4, p. 14).
Dearmond noted Nichols had trouble breathing through his nose again and had a large nasal
polyp blocking nasal passage on December 8, 2020 (Doc. 141-3, pp. 97-99; Doc. 140-6, p. 566).
She prescribed Nichols another 125 IM shot of Solumedrol, a corticosteroid injection, and another
20-day prescription of Prednisone (20 mg daily for ten days, 10mg daily for ten days, and then
stop). Id.; Doc. 141-6, p. 773.
On December 10, 2020, Dr. Siddiqui and Dr. Ritz had another “collegial review” and

Wexford approved the ENT follow up. The “Notice of Approval” for the ENT follow up
appointment was sent to Menard on December 14, 2020. (Doc. 141-2, pp. 123-124; Doc. 140-7,
p. 606). The December 14, 2020, Wexford “Notice of Approval” for the ENT follow up
appointment specifically stated that Nichols had a prior polypectomy in 2013, and the nasal polyps
were “treated multiple times with Prednisone and antibiotics without relief” (Doc. 140-7, p. 606).
On December 21, 2020, SIH ENT Dr. Mann and Absher reviewed the CT scans and
referred Nichols to Dr. Schneider at Washington University in St. Louis because his surgical
subspecialty focused on the sinus and naval cavities. (Doc. 139-4, pp. 21-23). Nichols would need
approval from Wexford to see Dr. Schneier (Doc. 141-2, pp. 135, 166).
On January 7, 2021, Nichols wrote a sick call request to see a doctor because swollen
polyps in his nose were causing him to choke. (Doc. 141-3, pp. 103-104). On January 10, 2021,
Nichols complained to RN Lee Grayson of sinus drainage from the swollen polyps were causing
him to choke. Id.; Doc. 140-6, p. 571. Nichols was referred to the MD call-line on January 10,
2021, by Grayson, but he did not see a provider because Menard was on a lockdown and the

appointment with a physician was never rescheduled. (Doc. 141-3, pp. 104-105). Nichols
continued having trouble breathing with nasal polyps visibly protruding from his nose, constant
coughing, and inability to speak in complete sentences (Doc. 141-8, at ¶ 3-7).
On January 25, 2021, at 2:30 a.m., Nichols was taken to the HCU with shortness of breath
and symptoms of an upper respiratory infection. Nichols said he could not breathe and was
choking on mucus in his throat that he could not cough up (Doc. 141-4, pp. 40-47; Doc. 140-6, pp.
574-577). RN Rable noted that Nichols was wheezing, had abnormal lung sounds and overused
his Xopenex inhaler, known as the “rescue inhaler,” which is a sign of out-of-control asthma.
Nichols peak flows were measured at 150 (Doc. 141-4, p. 46). Rable believed she had an “urgent

consultation” with Dr. Siddiqui and did not admit Nichols to the infirmary. Id. Rable documented
Nichols had symptoms of an upper respiratory infection (URI), filled out the URI and shortness of
breath (SOB) protocol sheets, and noted that Nichols was coughing and wheezing and had
abnormal lung sounds (Doc. 126-5, pp. 574-577; Doc. 141-4, pp. 46-49). Nichols told Rable that
he could not breathe and was choking on mucus in his throat that he could not cough up. Id.; Doc.
126-5, pp. 574-577. Rable gave Nichols a cold pill and nebulizer treatment and he was returned
to his cell at 3:00 a.m. (Doc. 141-4, p. 50; Doc. 140-6, pp. 574-577).
On January 26, 2021, Dearmond saw Nichols in the HCU in response to Rable’s request
for an “urgent consultation” (Doc. 141-4, pp. 112-113; Doc. 140-6, p. 578). On January 26, 2021,
Dearmond noted that Nichols had been choking all night, was unable to sleep, used his inhaler
more, and was unable to breathe well through his nose due to his nasal polyps. Id. Dearmond
observed that Nichols had large nasal polyps and was unable to visualize past the polyp in the left
nostril. Id. She gave Nichols another 125 IM shot of Solumedrol, a corticosteroid injection, and
prescribed another 20-day prescription of Prednisone (20 mg twice a day for ten days, then 10 mg

twice a day for ten days). Id.; Doc. 141-3, pp. 114-115; Doc. 141-2, p. 153; Doc. 141-6, p. 775.
When Nichols was returned to his cell on January 26, 2021, he continued to cough and struggle to
breathe and choke on mucus that he could not cough up (Doc. 141-8, ¶ 12).
On January 28, 2021, Nichols was coughing excessively throughout the day and his
cellmate, Melvin Jones, and Darnell Polk, who was in the cell next to Nichols, yelled for a “Med
Tech” (Doc. 141-8, ¶¶ 13, 14). Rable received a call to come to Nichols’ cell because he was
having trouble breathing. (Doc. 141-4, pp. 52-53). Rable instructed correctional officers to get a
“stair chair” to transport Nichols to the HCU. Id. at p. 54. Nichols stopped breathing while being
transported from his cell on the eighth floor to the HCU handcuffed in the “stair chair.” Id. at p.

59. He was taken to the HCU where life saving measures were unsuccessful and was pronounced
dead at 8:41 p.m. on January 28, 2021. Id. at pp. 60, 66.
Dr. Gershom Norfleet performed a postmortem examination on January 29, 2021, and
determined Nichols’ cause of death was bronchial asthma exacerbation. (Doc. 141-9, p. 548; Doc.
126-2, pp. 20-21, p. 30). Nichols’ autopsy showed that his lungs were abnormally swollen with
fluid and congested with blood. Id. The air passages were lined with “tenacious yellow mucus
plugs” that clogged up the airways. Nichols’ stomach was distended with air and contained
approximately 75 ml of partially digested gastric contents mixed with mucus. The microscopic
examination of Nichols’ lung cells showed: congestion of the pulmonary vascular, meaning the
blood vessels in the tissue sample were congested; an unusually high amount of “eosinophils,” a
type of white blood cells that were within the mucus located within in the bronchial and bronchiolar
lumens or smaller airways of the lungs, and submucosa, the cell layer beneath the larger airway;
and thickening of the bronchial basement membrane, which is beneath the lining of the lung cavity.
Id. at pp. 39-44.

Discussion
Summary judgment is proper only if the moving party can demonstrate that there is no
genuine issue as to any material fact. Fed. R. Civ. P. 56(a); Celotex Corp. v. Catrett, 477 U.S.
317, 322 (1986). The moving party is entitled to summary judgment where the non-moving party
“has failed to make a sufficient showing on an essential element of her case with respect to which
she has the burden of proof.” Celotex, 477 U.S. at 323. If the evidence is merely colorable, or is
not sufficiently probative, summary judgment may be granted. Anderson v. Liberty Lobby, Inc.,
477 U.S. 242, 249–50 (1986). Any doubt as to the existence of a genuine issue of material fact
must be resolved against the moving party. Lawrence v. Kenosha County, 391 F.3d 837, 841 (7th

Cir. 2004). Cross-motions for summary judgment do not automatically mean that all questions of
material fact have been resolved. Franklin v. City of Evanston, 384 F.3d 838, 842 (7th Cir. 2004).
The Court must evaluate each motion independently, making all reasonable inferences in favor of
the nonmoving party with respect to each motion. Id. at 483.
The Eighth Amendment prohibits “cruel and unusual punishment” of a prisoner. A prison
official's “deliberate indifference” to a prisoner's “serious medical needs” violates that mandate.
Perez v. Fenoglio, 792 F.3d 768, 776 (7th Cir. 2015). To support a claim of deliberate indifference,
a plaintiff must offer evidence that (1) he had an objectively serious medical condition, and (2) the
defendant acted with deliberate indifference to that condition. See Petties v. Carter, 836 F.3d 722,
728 (7th Cir. 2016) (en banc).
A medical professional who has treated a prisoner “is entitled to deference in treatment
decisions unless no minimally competent professional would have so responded under those
circumstances.” Campbell v. Kallas, 936 F.3d 536, 545 (7th Cir. 2019), quoting Sain v. Wood,

512 F.3d 886, 894–95 (7th Cir. 2008) (internal quotation omitted). In other words, to violate the
Eighth Amendment, a treatment decision must be “such a substantial departure from accepted
professional judgment, practice, or standards, as to demonstrate that the person responsible
actually did not base the decision on such a judgment.” Sain, 512 F.3d at 895, quoting Collignon
v. Milwaukee County, 163 F.3d 982, 988 (7th Cir. 1998). The “receipt of some medical care does
not automatically defeat a claim of deliberate indifference if a fact finder could infer the treatment
was so blatantly inappropriate as to evidence intentional mistreatment likely to seriously aggravate
a medical condition.” Edwards v. Snyder, 478 F.3d 827, 831 (7th Cir. 2007), quoting Snipes v.
DeTella, 95 F.3d 586, 592 (7th Cir. 1996); see also Arnett v. Webster, 658 F.3d 742, 751 (7th Cir.

2011) (“a prisoner [does not] need to show that he was literally ignored”).
Defendants’ Motion for Summary Judgment (Doc. 125)
Count I – Deliberate Indifference
Defendants move for summary judgment, arguing Nichols did not have a serious medical
need. While Defendants do not dispute that asthma could constitute a serious medical need, they
assert Plaintiff cannot establish that prior to January 28, 2021, the day he died, Nichols had a
serious medical need related to his asthma. The Court disagrees.
“As a general matter, asthma can be, and frequently is, a serious medical condition,
depending on the severity of the attacks.” Lee v. Young, 533 F.3d 505, 510 (7th Cir. 2008); see
also Garvin v. Armstrong, 236 F.3d 896, 898 (7th Cir. 2001) (observing that asthma, “depending
upon its degree, can be a serious medical condition”). Here, there is evidence in the record that
Nichols suffered from an objectively serious and well-documented medical condition as his
obstructive nasal polyps aggravated his asthmatic condition and made it difficult for him to
breathe. By January 2021, Nichols had gone through repeated rescue inhalers and complained to

Wexford providers that he was choking on mucus and having difficulty breathing due to the
swollen nasal polyps that were visibly protruding from his nose.
Defendants next contend that Dr. Siddiqui, Dr. Ritz, and NP Dearmond were not
deliberately indifferent to his asthma or nasal polyps because Nichols was seen in the asthma clinic
and provided inhalers and oral steroids to treat his nasal polyps. It is undisputed that Dr. Ritz was
not Nichols’ treating physician and there were no referrals to Dr. Ritz related to Nichols’ asthma
management. Dr. Ritz was not involved in Nichols’ medication decisions, including ordering
Prednisone. The extent of Dr. Ritz’s involvement with Nichol’s medical care were the approval
of the CT scan in September 2020 and approval of a follow-up ENT appointment in December

2020. The Court finds this record insufficient to establish an Eighth Amendment claim against
Dr. Ritz. Accordingly, Dr. Ritz is entitled to judgment as a matter of law.
As for Dr. Siddique and NP Dearmond, a reasonable jury could find that their actions
constituted deliberate indifference. An inmate can establish deliberate indifference by showing
that medical personnel persisted with a course of treatment they knew to be ineffective. See
Goodloe v. Sood, 947 F.3d 1026, 1031 (7th Cir. 2020); Greeno v. Daley, 414 F.3d 645, 654-55
(7th Cir. 2005). There is evidence in this case that despite knowing that Nichols had been treated
multiple times with Prednisone to no relief, he was repeatedly prescribed Prednisone on a daily
basis under the direction of Dr. Siddiqui: two months in a row in March and April of 2020; two
weeks in June 2020; 20 days in July 2020; 20 days in August 2020; 30 days in September 2020;
two weeks in November 2020; 20 days in December 2020; and on January 26, 2021, two days
before he died. Nichols was clearly taking Prednisone more than “two to three times a month,”
which Dr. Siddiqui and Defendants’ own expert consider “chronically excessive.” By December
2020, Nichols began choking due to the excess mucus caused by his visible polyps. The polyps

also caused Nichols to have trouble breathing. Dearmond noted on January 26, 2021 that Nichols
had been choking all night, was unable to sleep and was unable to breathe well through his nose
due to his nasal polyps. Dearmond treated him with oral steroids, including Prednisone, instead
of admitting him to the HCU. Nichols died two days later. Based on the record, a reasonable jury
could find that these defendants’ overuse of Prednisone and failure to admit Nichols to the HCU
in January 2021 amounted to deliberate indifference.
A reasonable jury could also conclude that the delay in Nichols’ priority ENT referral
constituted deliberate indifference. It is well established that an inexplicable delay in responding
to an inmate’s serious medical condition can reflect deliberate indifference. See Goodloe, 947

F.3d at 1031. This is particularly true if the delay exacerbates an inmate’s medical condition or
unnecessarily prolongs suffering. Id.; see also Williams v. Liefer, 491 F.3d 710, 715–16 (7th Cir.
2007). Defendants maintain that the COVID-19 restrictions prevented Nichols from being seen
by ENT sooner. However, Menard was only on a mandated Covid-19 lockdown from March to
June of 2020. Accordingly, Defendants Siddique and Dearmond are not entitled to judgment as a
matter of law on Count I of the First Amended Complaint.
Counts II and III – Wrongful Death and Survival Act
Plaintiff asserts a wrongful death action (Count II) and a survival action sounding in
negligence (Count III). The Illinois Wrongful Death Act, 740 ILCS 180/1, provides an
independent cause of action for damages arising from a decedent's death caused by wrongful act,
neglect or default. Kessinger v. Grefco, Inc., 623 N.E.2d 946, 948 (1993) (citations omitted). The

Act's purpose is to compensate a surviving spouse and next of kin for the pecuniary losses
sustained as a result of the decedent's death. Id. “Aside from the additional element of the
occurrence of death, the elements of a wrongful death claim are identical to those of a common
law negligence claim.” Williams v. Manchester, 864 N.E.2d 963, 974 (2007). A claim under the
Act requires proof that: “(1) defendant owed a duty to decedent; (2) defendant breached that duty;
(3) the breach of duty proximately caused decedent's death; and pecuniary damages arising
therefrom to persons designated under the Act.” Thompson v. City of Chicago, 472 F.3d 444, 457
(7th Cir. 2006) (quoting Leavitt v. Farwell Tower Ltd. Partnership, 625 N.E.2d 48, 52 (Ill. App.
1st Dist. 1993)). The Illinois survival statute does not create a statutory cause of action, but instead

allows a representative of the decedent to maintain those statutory or common law actions which
had already accrued to the decedent before he died. Myers v. Heritage Enters., Inc., 773 N.E.2d
767, 769 (2002).
As an initial matter, Defendants argue that Plaintiff failed to produce an affidavit as
required by 735 ILCS 5/2-622. Illinois law requires plaintiffs seeking medical malpractice
damages to attach written reports from health care professionals to their complaints. Hahn v.
Walsh, 762 F.3d 617, 633 (7th Cir. 2014). A plaintiff in federal court must procure the requisite
documentation, not during the pleading stage, but before the completion of the summary judgment
phase of the case. See Young v. United States, 942 F.3d 349, 351 (7th Cir. 2019) (“Section 5/2-
622 applies in federal court to the extent that it is a rule of substance; but to the extent that it is a
rule of procedure it gives way to Rule 8 and other doctrines that determine how litigation proceeds
in a federal tribunal.”) (emphasis in original).
Generally, “Illinois courts liberally construe certificates of merit in favor of the plaintiff,
recognizing the statute as a tool to reduce frivolous lawsuits by requiring a minimum amount of

merit, not a likelihood of success.” Sherrod v. Lingle, 223 F.3d 605, 613 (7th Cir. 2000). A
Section 5/2-622 report meets the statute's requirements if it is “sufficiently broad to cover each
defendant, adequately discusses deficiencies in the medical care given by defendants, and
establishes that a reasonable and meritorious cause exists for filing the action.” Id. (citation
omitted).
Dr. Herrington’s Report details the applicable standard of care, the manner in which the
standard was breached, and a causal connection between the breach and injury sustained. The
Report adequately discusses the deficiencies in the medical care provided by the defendants and
establishes that a cause of action exists under the circumstances. The “technical requirements of

this statute should not interfere with the spirit or purpose of the statute [because] the absence of
strict technical compliance is one of form only and not of substance. The technical requirements
of the statute should not be mechanically applied to deprive the plaintiff of her substantive rights.”
Comfort v. Wheaton Family Practice, 594 N.E.2d 381, 384 (2d Dist. 1992). The Court finds that
Dr. Harrington’s report satisfies the purpose of the statute.
Turning to the merits of Plaintiff’s wrongful death and survivor claims, Defendants contend
that they are entitled to judgment as a matter of law because they timely responded to Nichols’
complaints and ordered approved treatment aimed at reducing his symptoms while he was being
assessed by specialty care. Whether Defendants breached their duty owed to Nichols is clearly in
dispute. Plaintiff’s expert opines that they did, while Defendants deny any such breach. And
whether a breach of Defendants’ duties proximately caused Nichols’ injuries is a question of fact
that must be decided by the jury. See Shick v. Ill. Dep't of Human Servs., 307 F.3d 605, 615 (7th
Cir. 2002) (Whether or not the defendant's conduct proximately caused the plaintiff's injury
ordinarily is a question for the finder of fact to decide; only rarely are the facts so clear that the

court can resolve the issue as a matter of law). Accordingly, Defendants’ motion for judgment as
to Counts II and III is denied.
Plaintiff’s Partial Motion for Summary Judgment (Doc. 130)
Plaintiff moves for partial summary judgment on her survival claim, asserting it is
undisputed that: (1) Nichols continued to experience pain and suffering from the obstructive nasal
polyps as Wexford healthcare providers at Menard repeatedly treated his condition with a steroid
medication they knew were ineffective; and (2) Nichols suffered as a result of the delays to get
him to a surgical specialist to remove the polyps prior to his death.
Again, whether Defendants were deliberately indifferent and/or breached their duty to

Nichols are factual disputes for the jury to decide. Accordingly, Plaintiff’s motion for summary
judgment is denied.
Conclusion

For the foregoing reasons, Defendants’ Motion for Summary Judgment (Doc. 125) is
GRANTED in part and DENIED in part. Plaintiff’s Partial Motion for Summary Judgment
(Doc. 130) is DENIED. Plaintiff’s claims against Defendants Mohammed Siddiqui and Ali
Dearmond (Counts I) and against Defendant Wexford Health Sources, Inc. (Counts II and III) will
proceed to trial. Plaintiff’s claims against Defendant Stephen Ritz (Count I) and Plaintiff’s Monell
claim against Defendant Wexford Health Sources, Inc. (Count IV) are DISMISSED with
prejudice. The Clerk of Court is DIRECTED to enter judgment accordingly at the close of the
case.
IT IS SO ORDERED.
DATED: December 3, 2025

STACI M. YANDLE
United States District Judge

Page 20 of 20

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/cases/11213744. Public record. Not legal advice.